Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03034642 · ClinicalTrials.gov registry record · NA
Modulation of Steroid Immunosuppression by Alveolar Efferocytosis
A NA study, sponsored by VA Ann Arbor Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03034642 is a NA study that has completed, run by VA Ann Arbor Healthcare System. The registered enrollment target is 60 participants.
The verdict
NCT03034642, a NA study, has completed, sponsored by VA Ann Arbor Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The long-term goals of this study are (a) to understand the biological underpinnings for the increased incidence of community-acquired pneumonia in patients with chronic obstructive pulmonary disease (COPD) who are treated with inhaled corticosteroids; and (b) to develop novel therapies to treated this problem using over-expression of micro-RNAs (miRNAs).
Interventions
- PROCEDURE Bronchoscopy with bilateral bronchoalveolar lavages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2015-10-01 |
| Est. Completion | 2021-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03034642
The ClinicalTrials.gov registry entry for NCT03034642 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Ann Arbor Healthcare System, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bronchoscopy with bilateral bronchoalveolar lavages is the first listed.
NCT03034642 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03034642 about?
NCT03034642 is a clinical study titled "Modulation of Steroid Immunosuppression by Alveolar Efferocytosis". The long-term goals of this study are (a) to understand the biological underpinnings for the increased incidence of community-acquired pneumonia in patients with chronic obstructive pulmonary disease (COPD) who are treated with inhaled corticosteroids; and (b) to develop novel therapies to treated t...
What is the current status of trial NCT03034642?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2015-10-01. Estimated completion is 2021-12-30.
What interventions are being tested in trial NCT03034642?
The interventions under investigation include: Bronchoscopy with bilateral bronchoalveolar lavages (PROCEDURE).
Who is sponsoring clinical trial NCT03034642?
This trial is sponsored by VA Ann Arbor Healthcare System, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.